NOUL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,620 KRW | +1.95% |
|
-6.76% | -35.47% |
| 04-25 | Noul Announces 2 Clinical Performance Studies At Pan-African Malaria Conference | CI |
| 2023 | Noul Co., Ltd. Unveils the Result of Malaria Study in Ethiopia and Ghana | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 70.25M | - | - | - | - | - | |
| 7.8B | - | |||||
| 3.53B | - | |||||
| 1.84B | - | - | - | - | - | |
| 1.66B | - | |||||
| 951M | - |
- Stock Market
- Equities
- A376930 Stock
- Charts Noul Co.,Ltd.
- Sector Chart
